Mavora offers clear, evidence-aware information on investigational ibogaine use in the context of methadone dependence. Our work emphasizes uncertainty, serious cardiac risks, and established treatment options while remaining independent of clinics and providers.
We exist because people and clinicians need concise, cautious context when encountering investigational therapies. If you arrived here from the site summary, you can return to the main overview at the site's landing by following the editorial link to the homepage (it links back to the site's front page in sentence form).
When readers want to explore what services or editorial summaries we reference, we describe those pathways clearly and include links to provider directories such as local treatment directories within explanatory prose elsewhere on the site.
We curate and summarize primary literature, clinical registries, and recognised guidance so readers can see the evidence context without wading through paywalled journals. Where appropriate we link to trial registries and clinical program descriptions; for example, readers sometimes follow descriptions of time course from community resources such as resources on ibogaine duration when comparing protocols.
How we vet sources
We also point to clinics and treatment programs descriptively when they are publicly listed; an example of such program listings is used in context when discussing regional availability like treatment program descriptions in Mexico.
High-level summaries of investigational approaches, safety signals, and the types of evidence available. We do not provide clinical recommendations or personalized tapering plans.
Readers interested in procedural descriptions sometimes explore topics such as cognitive effects through resources like ibogaine and cognition summaries we reference in context.
Patients, supporters, and clinicians who want a careful synthesis of evidence and risks—particularly those evaluating investigational therapies alongside established care.
For people seeking services, our pages link to descriptions of offerings and service models such as provider listings and success-rate discussions like treatment outcome summaries when that context is relevant.
Content is arranged into explanatory summaries, an evidence page aggregating trial results, and a clinical-risks section that focuses on safety data and monitoring considerations.
When readers encounter unfamiliar terminology, we link to descriptive glossaries such as pages explaining alternative terminology and synonyms like other names for ibogaine as inline clarifications, never as endorsements.
Our work is guided by a concise set of values meant to keep reporting precise and cautious.
Mavora is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice. Readers seeking individualized medical guidance should consult a licensed professional, and we link to official clinical guidance and registry information where appropriate — for example, authoritative registry or academic pages used for verification when possible (Wikipedia: Clinical trial and a clinical research primer at NIH are typical external references we draw on).
If you want descriptions of offerings we reference editorially, our Services page summarises what we describe about program types and sourcing; see the site’s service overview at our services page for the editorial framing and how we treat external program listings. For readers comparing experiential timelines or cognitive outcomes, we sometimes cite external specialist pages and registries to be transparent about uncertainty and known risks.